Abstract
Baloxavir marboxil (Xofluza (TM); baloxavir) is an oral cap-dependent endonuclease inhibitor that has been developed by Roche and Shionogi. The drug b......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
